|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
61,413,000 |
Market
Cap: |
10.50(B) |
Last
Volume: |
430,952 |
Avg
Vol: |
505,049 |
52
Week Range: |
$114.17 - $208.42 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems used in the process of manufacturing biological drugs. Co.'s bioprocessing business is comprised of:Filtration, which includes XCell Alternating Tangential Flow systems that are used in upstream perfusion cell culture processing; Chromatography, which includes products used in downstream purification, development, manufacturing and quality control of biological drugs; Process Analytics, which complements and supports its Filtration, Chromatography and Proteins franchises; and Proteins, which are represented by its Protein A affinity ligands and cell culture growth factor products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,500 |
Total Buy Value |
$0 |
$0 |
$0 |
$238,260 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
25,597 |
25,597 |
30,235 |
146,471 |
Total Sell Value |
$5,039,534 |
$5,039,534 |
$5,742,535 |
$29,817,809 |
Total People Sold |
4 |
4 |
5 |
6 |
Total Sell Transactions |
4 |
4 |
6 |
17 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Snodgres Jon |
CFO |
|
2016-07-14 |
4 |
D |
$26.56 |
$8,605 |
D/D |
(324) |
17,453 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2016-06-30 |
4 |
S |
$26.60 |
$133,010 |
D/D |
(5,000) |
12,094 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2016-06-28 |
4 |
S |
$24.59 |
$245,888 |
D/D |
(10,000) |
17,094 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2016-06-28 |
4 |
OE |
$3.22 |
$16,100 |
D/D |
5,000 |
27,094 |
|
- |
|
Dawes Karen A |
Director |
|
2016-06-27 |
4 |
D |
$23.46 |
$46,498 |
D/D |
(1,982) |
55,764 |
|
- |
|
Dawes Karen A |
Director |
|
2016-06-27 |
4 |
OE |
$3.10 |
$46,500 |
D/D |
15,000 |
57,746 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2016-05-24 |
4 |
OE |
$6.23 |
$62,300 |
D/D |
10,000 |
28,626 |
|
- |
|
Cox John |
Director |
|
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,763 |
3,621 |
|
- |
|
Muir Glenn P |
Director |
|
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,763 |
1,763 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,763 |
22,094 |
|
- |
|
Cooper Glenn L Md |
Director |
|
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,763 |
37,094 |
|
- |
|
Barthelemy Nicholas |
Director |
|
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,763 |
2,782 |
|
- |
|
Dawes Karen A |
Director |
|
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,505 |
42,746 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2016-05-11 |
4 |
S |
$26.72 |
$77,199 |
D/D |
(2,889) |
18,626 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2016-05-05 |
4 |
D |
$25.71 |
$41,702 |
D/D |
(1,622) |
73,342 |
|
- |
|
Rusche James R |
Senior Vice President |
|
2016-02-29 |
4 |
D |
$26.05 |
$36,965 |
D/D |
(1,419) |
100,516 |
|
- |
|
Snodgres Jon |
CFO |
|
2016-02-29 |
4 |
D |
$26.05 |
$19,485 |
D/D |
(748) |
17,777 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2016-02-29 |
4 |
D |
$26.05 |
$33,917 |
D/D |
(1,302) |
21,515 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2016-02-29 |
4 |
D |
$26.05 |
$59,055 |
D/D |
(2,267) |
74,964 |
|
- |
|
Rusche James R |
Senior Vice President |
|
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,086 |
101,935 |
|
- |
|
Snodgres Jon |
CFO |
|
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,905 |
18,525 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,263 |
22,817 |
|
- |
|
Hunt Anthony |
Chief Executive Officer |
|
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
33,589 |
77,231 |
|
- |
|
Benjamin Howard |
VP Business Development |
|
2015-11-19 |
4 |
OE |
$3.33 |
$16,650 |
D/D |
5,000 |
16,554 |
|
- |
|
Dawes Karen A |
Director |
|
2015-11-10 |
4 |
A |
$26.70 |
$26,700 |
D/D |
1,000 |
40,241 |
|
- |
|
464 Records found
|
|
Page 16 of 19 |
|
|